November 14, 2022

Camilla Sønderby joins the Novo Holdings Advisory Group

Novo Holdings is pleased to announce the appointment of Camilla Sønderby to the Novo Advisory Group (NAG), an expert panel of senior industry leaders that supports Novo Holdings in analysing and monitoring its larger life science investments.

Kasim Kutay, CEO of Novo Holdings, said: “With her strong market insights and sector expertise within biopharma and pharma services, Camilla brings key competencies to our Advisory Group’s work. I am delighted to welcome Camilla to the NAG and very much look forward to her contributions.”

Camilla Sønderby has more than 20 years’ international leadership experience from major pharmaceutical companies, most recently at Takeda, where she headed global portfolio commercialisation and global commercial excellence and was member of the executive committee.

Prior to joining Takeda in 2019, Camilla held various senior operational and strategic positions at Shire, Abbott (now AbbVie), Roche and Schering Plough, covering Europe, USA and Asia. In addition to working with pharma commercialisation, portfolio strategy and collaborating closely with R&D, she has extensive general management and transformation experience. Camilla began her career as management consultant at McKinsey & Co.

Camilla Sønderby said: “It is an honour to join the Novo Advisory Group. Novo Holdings has an impressive track record and is a leading life science investor. I look forward to leveraging my experience to help Novo Holdings further increase its investments, in support of its noble mission.”

About Camilla Sønderby

Danish citizen

Current board positions and advisor roles
Camilla serves on the Boards of Directors of F2G (US/UK) and Affibody (Sweden), and is an Industrial Advisor for the private equity group EQT.

**Corporate Career
**2019 – 2020: Chief Patient Value & Product Strategy Officer, Takeda
2018 – 2019: Senior Vice President, Global Product Strategy, Shire (Acquired by Takeda)
2014 – 2015: Regional Head Pharma, Central, Eastern and Southern Europe, Roche Pharmaceuticals
2008 – 2013: General Manager, Abbott Sweden and subsequently Abbott UK
2002 – 2007: Various positions at Schering-Plough in Asia and South Africa, including as General Manager, Taiwan and Turnaround Project Manager for China subsidiary
1999 – 2002: McKinsey & Company, Management Consultant serving healthcare industry clients

Camilla holds a MSc in Political Science from the University of Copenhagen.

Further information

Nils Eskestad, Senior Communications Manager, +45 3023 2904,